FTC's Big ViroPharma Loss Has Antitrust Silver Lining
The Federal Trade Commission suffered a big setback when a Delaware federal judge axed its milestone challenge to ViroPharma Inc.'s anti-generic maneuvering, but the agency simultaneously notched a victory that will...To view the full article, register now.
Already a subscriber? Click here to view full article